EYPT EyePoint Pharmaceuticals Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
11:32
Aug 18
Aug 18
JPMorgan, TD Cowen, Citigroup, Jefferies, and other firms raised price targets on twelve stocks.
JPMorgan, TD Cowen, Citigroup, Jefferies, and other firms raised price targets on twelve stocks while cutting targets on six others and initiating or resuming coverage on six additional names.
11:31
Aug 18
Aug 18
JPMorgan, KeyBanc, Citi, and other firms issue multiple upgrades and downgrades across a broad.
JPMorgan, KeyBanc, Citi, and other firms issue multiple upgrades and downgrades across a broad range of stocks with various price target adjustments.
20:26
Aug 17
Aug 17
EyePoint trial failure drives record drop.
EyePoint shares had a record drop after its experimental wet age-related macular degeneration treatment failed the primary goal in a late-stage trial, and Cantor cut the stock to neutral, calling the failure a scenario they had not contemplated.
HIGH
12:17
Aug 17
Aug 17
Premarket movers show mixed Mag 7 performance, AI-linked stocks rising on Anthropic revenue.
Premarket movers show mixed Mag 7 performance, AI-linked stocks rising on Anthropic revenue news, and notable single-stock moves including Diana Shipping up 9%, EyePoint down 66% on trial failure, and Target Hospitality up 3% on Morgan Stanley overweight initiation.
22:30
Aug 08
Aug 08
Notes upcoming catalysts from analyst reports
Notes upcoming catalysts for the tickers based on Cowen and UBS reports, no directional view stated.
MED
About EYPT Analyst Coverage
Buzzberg tracks EYPT (EyePoint Pharmaceuticals Inc.) across 4 sources. 0 bullish vs 0 bearish calls from 4 analysts. Sentiment: evenly split. 5 total trade ideas tracked. Past 7 days: 4 watch. Latest voices: DeItaone, Joe Deaux, zerohedge.